Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???

Jacobs, C F; Soesan, M; Sonke, G S

Jacobs, C F; Soesan, M; Sonke, G S.

Afiliação

Jacobs CF; Department of Medical Oncology, The Netherlands Cancer Institute, NKI-AvL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Soesan M; Department of Medical Oncology, The Netherlands Cancer Institute, NKI-AvL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. m.soesan@nki.nl.
Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, NKI-AvL, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Breast Cancer Res Treat ; 192(3): 485-489, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35132502

Assuntos

Neoplasias da Mama; Antineoplásicos Hormonais/uso terapêutico; Inibidores da Aromatase; Quimioterapia Adjuvante; Intervalo Livre de Doença; Feminino; Hormônios; Humanos; Tamoxifeno

Palavras-chave

Chemotherapy; Concurrent therapy; Early breast cancer; Endocrine therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google